Carboxymethyl-hexanoyl Chitosan Nanodroplets for Ultrasonic Imaging and Drug Delivery to Tumor.
CONCLUSIONS: CHC-PFP-DOX holds great promise in simultaneous cancer-targeting US imaging and ultrasound-mediated delivery for cancer theranostics.
PMID: 29766795 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Jinsui Y, Bing S, Muhua L, Yue L, Jianyi L, Meng D, Kuan C, Chaopin Y, Hui Z, Zhiyi C Tags: Curr Pharm Des Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Men | Nanotechnology | Ovarian Cancer | Ovaries | Study | Toxicology | Ultrasound